Ignite Creation Date:
2024-05-05 @ 5:14 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00417911
Status:
COMPLETED
Last Update Posted:
2010-06-22
First Post:
2007-01-03
Brief Title:
Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients
Sponsor:
Nordic Myeloma Study Group
Organization:
Nordic Myeloma Study Group
Organization Data
Organization:
Nordic Myeloma Study Group
Class:
OTHER
Study ID:
NMSG 1505
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nordic Myeloma Study Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Ulf-Henrik Melqvist
Old Organization:
Nordic Myeloma Study Group Sahlgrenska University Hospital Gothenborg
Collaborators
| Name | Class |
|---|---|
| Janssen-Cilag Ltd | INDUSTRY |